Pfizer Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 28, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	9,829	8,031	2,119	31,372	21,979	9,159
Depreciation & Amortization	6,682	6,994	6,258	5,028	5,104	4,664
Asset Writedown & Restructuring Costs	4,040	4,261	3,440	586	363	2,066
Stock-Based Compensation	751	877	525	872	1,182	755
Other Operating Activities	-4,175	-4,342	-1,485	-2,946	-8,943	-5,797
Change in Accounts Receivable	-109	-109	347	261	-3,811	-1,275
Change in Inventory	-854	-854	-1,169	-591	-1,125	-778
Change in Accounts Payable	-1,023	-1,023	-300	1,191	1,242	355
Change in Other Net Operating Assets	-2,032	-1,080	-1,050	-6,500	16,498	1,391
Operating Cash Flow	13,077	12,744	8,700	29,267	32,580	14,403
Operating Cash Flow Growth	16.11%	46.48%	-70.27%	-10.17%	126.20%	14.42%
Capital Expenditures	-2,701	-2,909	-3,907	-3,236	-2,711	-2,226
Cash Acquisitions	-	-	-43,430	-22,997	-	-
Investment in Securities	5,559	5,561	15,239	10,642	-19,517	-1,672
Other Investing Activities	314	-	-180	-192	-318	-373
Investing Cash Flow	3,172	2,652	-32,278	-15,783	-22,546	-4,271
Short-Term Debt Issued	-	8,907	7,686	3,891	-	12,352
Long-Term Debt Issued	-	-	30,831	-	997	5,222
Total Debt Issued	4,419	8,907	38,517	3,891	997	17,574
Short-Term Debt Repaid	-	-13,816	-3	-4,109	-96	-26,326
Long-Term Debt Repaid	-	-2,250	-2,569	-3,298	-2,004	-4,003
Total Debt Repaid	-10,298	-16,066	-2,572	-7,407	-2,100	-30,329
Net Debt Issued (Repaid)	-5,879	-7,159	35,945	-3,516	-1,103	-12,755
Repurchase of Common Stock	-	-	-	-2,000	-	-
Common Dividends Paid	-9,706	-9,512	-9,247	-8,983	-8,729	-8,440
Dividends Paid	-9,706	-9,512	-9,247	-8,983	-8,729	-8,440
Other Financing Activities	-429	-469	-632	-335	16	11,546
Financing Cash Flow	-16,014	-17,140	26,066	-14,834	-9,816	-9,649
Foreign Exchange Rate Adjustments	7	-66	-40	-165	-59	-8
Miscellaneous Cash Flow Adjustments	-	-	1	-	-	-
Net Cash Flow	242	-1,810	2,449	-1,515	159	475
Free Cash Flow	10,376	9,835	4,793	26,031	29,869	12,177
Free Cash Flow Growth	26.12%	105.19%	-81.59%	-12.85%	145.29%	15.51%
Free Cash Flow Margin	16.53%	15.46%	8.05%	25.73%	36.74%	29.24%
Free Cash Flow Per Share	1.82	1.73	0.84	4.54	5.23	2.16
Cash Interest Paid	3,152	3,227	2,215	1,442	1,467	1,641
Cash Income Tax Paid	4,104	3,605	3,147	7,867	7,427	3,153
Levered Free Cash Flow	14,303	12,777	5,560	25,485	30,940	10,761
Unlevered Free Cash Flow	15,990	14,709	6,941	26,259	31,747	11,666
Change in Working Capital	-4,018	-3,066	-2,172	-5,639	12,804	-307

Source: S&P Global Market Intelligence. Standard template. Financial Sources.